Sustained remissions with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children with relapsed/refractory ALL

被引:115
|
作者
Maude, Shannon L.
Teachey, David T.
Rheingold, Susan R.
Shaw, Pamela A.
Aplenc, Richard
Barrett, David Maxwell
Barker, Christine S.
Callahan, Colleen
Frey, Noelle V.
Nazimuddin, Farzana
Lacey, Simon F.
Zheng, Zhaohui
Levine, Bruce
Melenhorst, Jan Joseph
Motley, Laura
Porter, David L.
June, Carl H.
Grupp, Stephan A.
机构
[1] Childrens Hosp Philadelphia, Philadelphia, PA USA
[2] Univ Pennsylvania, Philadelphia, PA USA
[3] Univ Pennsylvania, Abramson Canc Ctr, Philadelphia, PA USA
[4] Univ Pennsylvania, Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA
[5] Univ Pennsylvania, Lymphoma Program, Abramson Canc Ctr, Philadelphia, PA USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.3011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3011
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Wei, Guoqing
    Ding, Lijuan
    Wang, Jiasheng
    Hu, Yongxian
    Huang, He
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [42] Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia
    Guoqing Wei
    Lijuan Ding
    Jiasheng Wang
    Yongxian Hu
    He Huang
    Experimental Hematology & Oncology, 6
  • [43] Sustained Therapeutic Efficacy of Humanized Anti-CD19 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Heng, Gang
    Jia, Jiankun
    Li, Shiqi
    Fu, Gang
    Wang, Meiling
    Qin, Dabing
    Li, Yunyan
    Pei, Li
    Tian, Xiaobo
    Zhang, Jiasi
    Wu, Yi
    Xiang, Shali
    Wan, Jia
    Zhu, Wei
    Zhang, Pei
    Zhang, Qianzhen
    Peng, Xi
    Wang, Linling
    Wang, Ping
    Wei, Zhihao
    Zhang, Yingzi
    Wang, Guiqin
    Chen, Xue
    Zhang, Chengcheng
    Sun, Yanni
    Zhao, Wenxu
    Fan, Yahan
    Yang, Zhi
    Chen, Jieping
    Qian, Cheng
    CLINICAL CANCER RESEARCH, 2020, 26 (07) : 1606 - 1615
  • [44] Tumor Targeting Using CD19-Specific CAR (Chimeric Antigen Receptor) for B-Cell Lymphoma
    Tsukahara, Tomonori
    Ohmine, Ken
    Uchibori, Ryosuke
    Ido, Hiroyuki
    Urabe, Masashi
    Mizukami, Hiroaki
    Kume, Akihiro
    Nakamura, Masataka
    Mineno, Junichi
    Takesako, Kazutoh
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier
    Ozawa, Keiya
    MOLECULAR THERAPY, 2013, 21 : S248 - S249
  • [45] Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
    H Singh
    J S E Moyes
    M H Huls
    L J N Cooper
    Cancer Gene Therapy, 2015, 22 : 95 - 100
  • [46] The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL)
    Maude, Shannon L.
    Hucks, George E.
    Self, Alix Eden
    Talekar, Mala Kiran
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Gupta, Minna
    Frey, Noelle V.
    Porter, David L.
    Levine, Bruce L.
    Melenhorst, Jan J.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy
    Bhoj, Vijay
    Milone, Michael C.
    June, Carl H.
    Porter, David
    Grupp, Stephan A.
    Melenhorst, Jan J.
    Lacey, Simon F.
    Callahan, Colleen
    Capobianchi, James
    Wertheim, Gerald
    Mahnke, Yolanda
    BLOOD, 2014, 124 (21)
  • [48] CD19-specific car-t cells for the treatment of cns chloromas in children with relapsed/refractory b-cell acute lymphoblastic leukemia
    Shahid, S.
    Cancio, M.
    Haque, S. S.
    Khakoo, Y.
    McWilliams, E.
    Santomasso, B. D.
    Scaradavou, A.
    Spitzer, B.
    Wolden, S. L.
    Boelens, J. J.
    Curran, K. J.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 137 - 138
  • [49] Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
    Singh, H.
    Moyes, J. S. E.
    Huls, M. H.
    Cooper, L. J. N.
    CANCER GENE THERAPY, 2015, 22 (02) : 95 - 100
  • [50] Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Myers, Regina M.
    Li, Yimei
    Leahy, Allison Barz
    Barrett, David M.
    Teachey, David T.
    Callahan, Colleen
    Fasano, Christina C.
    Rheingold, Susan R.
    DiNofia, Amanda
    Wray, Lisa
    Aplenc, Richard
    Baniewicz, Diane
    Liu, Hongyan
    Shaw, Pamela A.
    Pequignot, Edward
    Getz, Kelly D.
    Brogdon, Jennifer L.
    Fesnak, Andrew D.
    Siegel, Donald L.
    Davis, Megan M.
    Bartoszek, Chelsie
    Lacey, Simon F.
    Hexner, Elizabeth O.
    Chew, Anne
    Wertheim, Gerald B.
    Levine, Bruce L.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (27) : 3044 - +